Log In
Print this Print this

fresolimumab (GC1008)

Also known as: GC-1008

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionPan-specific human mAb against transforming growth factor (TGF) beta
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today